3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
11
Nasopharyngeal Carcinoma
6
Oropharyngeal Neoplasms
5
Prostatic Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma
4
Mouth Neoplasms
3
Hypopharyngeal Neoplasms
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Mesothelioma
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Astrocytoma
2
Anus Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Mesothelioma, Malignant
1
Meningioma
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Locally Advanced Cervical Adenocarcinoma
1
HIV Infections
1
Glioma
1
Glioblastoma
1
Interventions
pembrolizumab
17
Bevacizumab
12
Standard of Care
10
Cyclophosphamide
9
Carboplatin
9
Doxorubicin
7
Cetuximab
7
Nivolumab
6
Exercise
6
olaparib
5
atezolizumab
5
Rituximab
5
Radiotherapy
5
Pemetrexed
5
Fluorouracil
5
Cisplatin
5
durvalumab
4
dostarlimab
4
abemaciclib
4
Temozolomide
4
Prednisone
4
Paclitaxel
4
Leucovorin
4
Blood Specimen Collection
4
venetoclax
3
temsirolimus
3
talazoparib
3
pertuzumab
3
obinutuzumab
3
ibrutinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.